Details for New Drug Application (NDA): 091027
✉ Email this page to a colleague
The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 091027
Tradename: | LITHIUM CARBONATE |
Applicant: | Sun Pharm Inds Inc |
Ingredient: | lithium carbonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 091027
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LITHIUM CARBONATE | lithium carbonate | TABLET;ORAL | 091027 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-430 | 62756-430-08 | 100 TABLET in 1 BOTTLE (62756-430-08) |
LITHIUM CARBONATE | lithium carbonate | TABLET;ORAL | 091027 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-430 | 62756-430-18 | 1000 TABLET in 1 BOTTLE (62756-430-18) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Jun 24, 2010 | TE: | AB | RLD: | No |
Complete Access Available with Subscription